SB Investment Advisers (uk) Ltd., 10% Owner at Vir Biotechnology, Inc. (VIR), sold 431,512 shares at $25.76 ($11.2M) on 2022-12-21, disclosed to the SEC on 2022-12-22.
Open-market sale of $11.2M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.53 | 104,026 | $2.7M | 23.8% |
| 2 | $25.53 | 104,026 | $2.7M | 23.8% |
| 3 | $25.76 | 15,927 | $410K | 3.7% |
| 4 | $25.76 | 15,927 | $410K | 3.7% |
| 5 | $26.19 | 95,803 | $2.5M | 22.5% |
| 6 | $26.19 | 95,803 |
| $2.5M |
| 22.5% |
| Total | $25.84 avg | 431,512 | $11.2M | 100% |
| Filing → |
| VIR | SELL | 2025-10-24 | $3.6M | — | Filing → |
| VIR | SELL | 2025-10-09 | $6.4M | — | Filing → |
| CPNG | SELL | 2025-06-17 | $282.5M | — | Filing → |